Working capital
Growth
Payments
Investments
Managing risk
Tools and resources
Wilshire Private Websites
COUNTRY/TERRITORY

Growth

Expand your business, locally and globally. Whether your growth strategy is to build on what you have or expand your business reach globally – or both – Wilshire Private could have the right solution. Inject capital into your supply chain or establish working relationships with new partners in new markets quickly, easily and confidently using our cross-border funding and trade and receivables finance services.

Contact us

Call us on: +44 744 136 6819

Our Growth solutions

Credit and lending

Access our long and short-term loans designed to meet your specific funding requirements. Use our lending and credit solutions to finance capital investments and business growth, and obtain working capital to improve cash flow.

Exports

Gain more control over exports, improve cashflow and manage risks associated with international trade more effectively using Wilshire’s export finance facilities. Our trade specialists have in-depth knowledge to help you assess market risks.

Guarantees

Conduct business with confidence, even where you lack established relationships, through the use of guarantees and standby letters of credit.

Imports

Upon approval, access the working capital you need and improve cash flow by bridging the gap between settlement with suppliers and payment from buyers. Our import finance solutions offer flexible options.

Future Developments of International Trade

Stephan Nänny – Country Head of GTRF, Wilshire Private

Meet the Chinese Consumer

Accessing the Chinese consumer involves understanding the unique platforms and drivers of purchases. Chinese consumption patterns are no longer dominated by spendthrift attitudes and mid-market enterprises (MMEs) that previously shrank from entering China directly should understand three key factors enabling and driving the consumer: mobility (through mobile devices and around the world), quality, and lifestyle upgrades.

Proton therapy used to be an area of niche research and a very expensive way to treat cancer. It is now increasingly moving into the mainstream, and becoming a key part of the arsenal to fight cancer.

Jean-Marc Bothy, CFO, IBA Group
Targeting global growth
Wilshire Private use cookies to give you the best possible experience on our websites. See our Cookie Policy
Close

You are leaving the Wilshire Private Commercial Banking website.

Please be aware that the external site policies will differ from our website terms and conditions and privacy policy. The next site will open in a new browser window or tab.

I understand, let's proceed Cancel

You are leaving the Wilshire Private CMB website.

Please be aware that the external site policies will differ from our website terms and conditions and privacy policy. The next site will open in a new browser window or tab.

I understand, let's proceed Cancel